Skip to Main Content

++

SOURCE

+

Source: Hayney MS. Vaccines and immunobiologics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 10th ed. New York, NY: McGraw-Hill; 2017. http://accesspharmacy.mhmedical.com/content.aspx?bookid=1861&sectionid=146073816. Accessed May 17, 2017.

++

DEFINITIONS

++

  • Immunization: process of introducing antigen into body to induce protection against infectious agent without causing disease.

    • Antigens: substances that induce immune response.

      • Humoral immune response produces antibodies that can be measured.

      • Cellular immune response is important but not measurable.

  • Vaccines: substances administered to generate protective immune response.

    • Can be live attenuated or killed.

  • Toxoids: inactivated bacterial toxins that retain ability to stimulate formation of antitoxins, antibodies directed against bacterial toxin.

  • Adjuvants: inert substances, such as aluminum salts (ie, alum), which enhance vaccine antigenicity by prolonging antigen absorption.

  • Immune sera: sterile solutions containing antibody derived from human (immunoglobulin [Ig]) or equine (antitoxin) sources.

++

VACCINE AND TOXOID RECOMMENDATIONS

++

  • Centers for Disease Control and Prevention (CDC) has comprehensive immunization schedules for children and adults.

  • Factors affecting response to immunization.

    • Viability of antigen (live attenuated vs. inactivated)

    • Total dose.

      • Interval between immunization doses.

      • Number of doses given.

    • Route and site of administration.

    • Host factors.

      • Immunocompromised.

      • Increasing age.

      • Underlying disease.

      • Genetic background.

  • Administration.

    • In general, inactivated vaccines can be administered simultaneously at separate sites.

    • Inactivated and live attenuated vaccines may be administered simultaneously at separate sites.

    • If live vaccines not administered simultaneously, their administration should be separated by at least 4 weeks.

    • The buttock should not be used because of the potential for inadequate immunologic response and the potential risk of injury to the sciatic nerve.

      • When the buttock must be used (as for large doses of Ig), only the upper outer quadrant should be used with the needle inserted anteriorly.

++

IMMUNIZATION OF SPECIAL POPULATIONS

++

  • Infants.

    • Live vaccines not administered until maternal antibodies have waned, generally by age 12 months.

    • Premature infants should be vaccinated at same chronologic age using same schedule and precautions for full-term infants.

  • Pregnant women and postpartum immunization.

    • Administration of live attenuated vaccines should not be done during pregnancy; inactivated vaccines may be administered to pregnant women when benefits outweigh risks.

      • Universal influenza immunization recommended for women who will be or are pregnant during influenza season.

      • Hepatitis B, hepatitis A, meningococcal, and inactivated polio vaccines should be administered to pregnant females if they are otherwise indicated.

    • Administration of live vaccines, such as rubella or varicella, deferred until postpartum.

  • Immunocompromised hosts.

    • In general, severely immunocompromised individuals should not receive live vaccines.

    • Patients with chronic conditions that cause limited immunodeficiency (eg, renal disease, diabetes, liver disease, and asplenia) and who are not receiving immunosuppressants may receive live attenuated and killed vaccines, as well as toxoids.

    • Patients with active malignant disease can receive killed vaccines or toxoids but should not be given live vaccines.

    • Glucocorticoids may cause suppressed responses to vaccines.

      • Wait 1 month to administer live ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.